Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Stilgenbauer

Showing results (201-210 of 466) with videos related to

Pageof 47
Sort By:
Blood|July 10, 2025
A noncoding mutation in the NOTCH1 gene initiates oncogenic NOTCH signaling via wild-type NICD stabilization in CLLMin Guo, Tugba Memis, Alena Sophie Ehrmann, et al.
European Journal of Haematology|August 1, 2024
Comparison of R-CHOP-14 and R-mini-CHOP in older adults with diffuse large B-cell lymphoma-A retrospective multicenter cohort studyZelal Guel Dilbaz, Sophy Denker, Carla Ankermann, et al.
Blood|July 4, 2013
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSGAndrea Schnaiter, Peter Paschka, Marianna Rossi, et al.
Blood|July 19, 2017
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trialIsabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, et al.
Leukemia|May 12, 2018
Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN studyStephan Stilgenbauer, Veronique Leblond, Robin Foà, et al.
Cellular & Molecular Biology Letters|July 3, 2024
Impairment of α-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasionJunnan Liu, Xue Wang, Wencheng Jiang, et al.
Blood|July 5, 2003
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcomeDirk Kienle, Alexander Kröber, Tiemo Katzenberger, et al.
Leukemia|May 16, 2019
Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemiaStephan Stilgenbauer, Thérèse Aurran Schleinitz, Barbara Eichhorst, et al.
Leukemia & Lymphoma|October 25, 2017
Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcomeDaniela Steinbrecher, Billy Michael Chelliah Jebaraj, Christof Schneider, et al.
Haematologica|March 28, 2008
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlationsSandrine Sander, Lars Bullinger, Elke Leupolt, et al.
Pageof 47

Showing results (201-210 of 466) with videos related to

Sort By:
Pageof 47
Blood|July 10, 2025
A noncoding mutation in the NOTCH1 gene initiates oncogenic NOTCH signaling via wild-type NICD stabilization in CLLMin Guo, Tugba Memis, Alena Sophie Ehrmann, et al.
European Journal of Haematology|August 1, 2024
Comparison of R-CHOP-14 and R-mini-CHOP in older adults with diffuse large B-cell lymphoma-A retrospective multicenter cohort studyZelal Guel Dilbaz, Sophy Denker, Carla Ankermann, et al.
Blood|July 4, 2013
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSGAndrea Schnaiter, Peter Paschka, Marianna Rossi, et al.
Blood|July 19, 2017
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trialIsabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, et al.
Leukemia|May 12, 2018
Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN studyStephan Stilgenbauer, Veronique Leblond, Robin Foà, et al.
Cellular & Molecular Biology Letters|July 3, 2024
Impairment of α-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasionJunnan Liu, Xue Wang, Wencheng Jiang, et al.
Blood|July 5, 2003
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcomeDirk Kienle, Alexander Kröber, Tiemo Katzenberger, et al.
Leukemia|May 16, 2019
Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemiaStephan Stilgenbauer, Thérèse Aurran Schleinitz, Barbara Eichhorst, et al.
Leukemia & Lymphoma|October 25, 2017
Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcomeDaniela Steinbrecher, Billy Michael Chelliah Jebaraj, Christof Schneider, et al.
Haematologica|March 28, 2008
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlationsSandrine Sander, Lars Bullinger, Elke Leupolt, et al.
Pageof 47